Impact of Chronic Cough on Activities of Daily Living and Response to Acute High-intensity Exercise

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Leeds

About this trial

Chronic cough is a common and debilitating condition that affects up to 10% of the global population. The health impact of chronic cough is multifaceted and manifests both physical and psychological symptoms including syncope, chest pain, lethargy, depression and anxiety. It is now also recognised that chronic cough often leads to social isolation and may impact an individual's ability or confidence to undertake routine daily tasks / lead an active lifestyle.

The primary aim of this study is therefore to characterise the impact of unexplained chronic cough on the ability to undertake daily activities - i.e., determine whether individuals with chronic cough exhibit impaired levels of physical activity during usual daily living when compared with healthy age, gender and BMI matched controls. A secondary aim is to assess the short-term impact of high-intensity exercise on cough (i.e., determine whether an acute bout of exercise alters cough frequency and/or severity).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age >18 years

Chronic cough as per European Respiratory Society definition (>8 weeks duration)

High symptom burden (i.e., cough visual analogue scale >40 mm at pre-study screening)

Chest radiograph or CT within 3 years of the screening visit with no abnormalities considered to contribute to chronic cough

Disqualifiers

Smokers or individuals who gave up smoking within 12 months

Smoking history >20 pack-years

Long-COVID or post-COVID syndrome (defined as symptoms lasting over 12-weeks in duration)

Recent exacerbation of cough within 4 weeks of inclusion

Trial population

Patients with unexplained chronic cough will be recruited from the Hull Cough Clinic, Castle Hill Hospital.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

129 Participants
are grouped into 1 trial group
Group A: Chronic cough as per European Respiratory Society definition (>8 weeks duration)

Trial outcomes

Primary outcomes

1

Physical activity status assessed using objective wearable accelerometer (ActiGraph LEAP)

Physical activity status including: \- Absolute daily steps

Time frame
1-week

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Leeds

Lead sponsor

Hull York Medical School

Collaborator

King's College Hospital NHS Trust

Collaborator

Royal Brompton & Harefield NHS Foundation Trust

Collaborator